Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm
Filename | 123. Vena et al., Alternat. treatm. CSU, COACI 2017.pdf |
Filesize | 255.08 KB |
Version | r.123 |
Date added | June 21, 2020 |
Downloaded | 0 times |
Category | Reviews |
Tags | alternative treatments, chronic spontaneous urticaria, guideline algorithm |
Authors | Vena, G. A., Maurer, M., Cassano, N., and Zuberbier, T. |
Citation | Vena, G. A., Maurer, M., Cassano, N., and Zuberbier, T.: Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm. Curr. Opin. Allergy Clin. Immunol. 2017: 17; 278-285. |
DocNum | r.123 |
DocType | |
Edition; Page | 17; 278-285. |
IF | 3.54 |
Publisher | Curr. Opin. Allergy Clin. Immunol. |
ReleaseDate | 2017 |
Purpose of review: The international EAACI/GA2LEN/EDF/WAO guideline suggests a stepwise approach for the therapeutic management of chronic spontaneous urticaria (CSU), outlined in an algorithm. The aim of this article is to summarize and review the evidence available on alternative treatment options for CSU outside of this algorithm.
Recent findings: Although CSU is a common disease, there are a limited number of high-quality studies, and only antihistamines and omalizumab are licensed for its treatment. Most studies regarding alternative therapies for CSU show methodological limitations and a high risk of bias. For many therapies, only case reports and uncontrolled studies exist. Recent publications on alternative treatments for chronic urticaria/CSU include reports on the use of adalimumab, rituximab, vitamin D, probiotics, histaglobulin, injection of autologous whole blood or serum, and phototherapy.
Summary: Numerous treatments beyond the guideline algorithm have been evaluated in patients with refractory CSU. The global level of evidence to support their efficacy in CSU is low or very low. Further research is needed to assess the efficacy and safety of alternative therapies of CSU to manage adequately those patients who do not respond to the treatments included in the algorithm.
(Last update: 12.2023)
Number of original publications in peer-reviewed journals: | 580 |
Number of reviews in peer-reviewed journals: | 210 |
Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.